ハギワラ　ノブヒサ   Nobuhisa Hagiwara   萩原　誠久    所属   その他 その他    職種   非常勤嘱託
言語種別	日本語
発表タイトル	Beta-blockers for Heart Failure Patients with Atrial Fibrillation: An Analysis of HIJ-HF II Multicenter Cohort Study
会議名	第83回日本循環器学会学術集会
主催者	日本循環器学会
学会区分	全国規模の学会
発表形式	口頭
講演区分	一般
発表者・共同発表者	◎大藪謙次郎, 鈴木敦, 松井優子, 長柄希実子, 春木伸太郎, 菊池規子, 服部英敏, 渡辺絵梨沙, 鈴木豪, 志賀剛, 萩原誠久
発表年月日	2019/03/30
開催地 （都市, 国名）	横浜市
概要	*Oral Presentation (Japanese)26 Heart Failure (Paharmacology) Atrial fibrillation (AF) are frequently observed in patients with heart failure (HF). However, the efficacy of betablockers (BB) in HF patients with AF is uncertain. The aim of this study was to assess the impact of beta-blockers (BB) on mortality among HF patients with AF. We studied 266 HF patients with concomitant AF (age: 76+/-12 years, 47% female) from a multicenter hospital-based cohort consisted of hospitalized HF patients between 2013 and 2014. 168 patients (63%) were receiving BB. BB patients were lower age, had lower rates of ventricular arrhythmias and lower left ventricular ejection fraction than non-BB patients. During 16 +/- 11 months follow-up, the total mortality was significantly lower in BB patients than non-BB patients (15% vs.21%) (Figure A). Compared to non-BB patients matched by using propensity scores based on baseline variables, BB patients had also a significant lower rates of mortality (Figure B). BB may improve prognosis for patients with concomitant HF and AF.